Featured Authors

Natalie Yeadon

Top 10 Tips to Increase Engagement During Virtual Events

If you are a member of the Medical Affairs Professional Society (MAPS), you might have caught our popular webinar on how COVID-19 has impacted...
Natalie Yeadon -
Natalie Yeadon

Top 10 Tips for Running a Successful Virtual Event

The ways that pharmaceutical and scientific communities attend meetings and events completely changed in 2020. Virtual events are rapidly improving, as are the platforms...
Natalie Yeadon -
Featured Authors

2020: looking back at the year when everything changed

A version of this article was previously published on Pharmaphorum. I think it’s fair to say that 2020 will not be particularly missed by anyone....
Natalie Yeadon -
Featured Authors

Top 10 Tips for Creating Company Culture in a Virtual World

For many companies, the transition from in-office to remote or flexible work at the beginning of the pandemic may have started off a bit...
Natalie Yeadon -
Natalie Yeadon

Top 10 Reasons Why Virtual Collaboration and Medical Education Will Persist in the New Normal

A version of this article was previously published on Pharmaphorum. There is not a single industry that has been left untouched by COVID-19. While the...
Natalie Yeadon -
Natalie Yeadon

Secondary effects of COVID-19 on the healthcare system and patients

A version of this article was previously published on Pharmaphorum. By now, your social media feeds are probably full of COVID-19-related news articles, opinion...
Natalie Yeadon -
1234Page 1 of 4

Recent Articles

Cortexyme Announces Clinical Hold on Atuzaginstat’s Investigational New Drug Application

Industry News

Molecular Targeting Technologies, Inc., Thomas Jefferson University and North China Pharmaceutical Co., Ltd Announced the Chinese Approval for a Rabies Drug

Industry News

Labcorp to Offer Risk-Scoring Test for People With Advanced Liver Fibrosis Due to NASH

Industry News

Melanoma Research Alliance Statement on FDA Approval of Tebentafusp, the First Drug for Treating Metastatic Uveal Melanoma

Industry News

NANOBIOTIX Announces Publication of New Preclinical Immunotherapy Data Showcasing the Combination Potential of NBTXR3 With anti-PD-1 and anti-CTLA-4

Industry News

Sheila A. Stamps Joins IQVIA Board of Directors

Look Who’s On the Move!

European Commission Approves Merck’s KEYTRUDA® (pembrolizumab) as Adjuvant Therapy for Certain Patients With Renal Cell Carcinoma (RCC) Following Surgery

Regulatory Affairs

Allay Therapeutics Appoints Ron Burch, M.D., Ph.D. to Scientific Advisory Board

Look Who’s On the Move!

4D pharma Announces Additional Positive Data From Part A of the Phase I/II Trial Of MRx-4DP0004 For the Treatment of Asthma

Industry News

Taysha Gene Therapies Announces Positive Initial Biomarker Data For TSHA-101, the First Bicistronic Gene Therapy in Clinical Development, Demonstrating Normalization of β-Hexosaminidase A Enzyme...

Industry News

AmerisourceBergen Welcomes New SVP and Chief Diversity Equity and Inclusion Officer, Ann Anaya

Look Who’s On the Move!

Glytec And Nebraska Medicine Establish Strategic Partnership to Advance Patient Safety and Innovation Around Insulin Management

Industry News

Quantori Names Pharma IT Veteran Arun Nayar as Global Head of R&D Informatics

Look Who’s On the Move!

AIHD Conference: Discover How Artificial Intelligence Is Changing the Healthcare Landscape

Industry News

Cystic Fibrosis Foundation Announces Steven Rowe, MD, as Next Chief Scientific Officer

Look Who’s On the Move!

2021 © Copyright - TPMG

Get a free copy of "Cracking the Generics Code"

Looks like you are using an ad-blocking browser extension. We request you to whitelist our website on the ad-blocking extension and refresh your browser to view the content.